When we talk about Parkinson’s disease (PD), we often focus on dopamine loss, Lewy bodies, or the latest neuroprotective drug in the pipeline. But behind every molecule that makes it to trial lies a more fundamental question — why are neurons dying in the first place? And increasingly, toxicology is providing the answer.